Selected research
Market Outlook & Growth Opportunities
Global Adult Immune Cell Storage Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Adult Immune Cell Storage Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Adult Immune Cell Storage Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Adult Immune Cell Storage Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Adult Immune Cell Storage Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Adult Immune Cell Storage Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Adult Immune Cell Storage Services market include Shanghai Cell Therapy Group, BGI Group, VCANBIO, CGT GLOBAL, Cordlife Group, ThermoGenesis, HealthBanks, BioLife Solutions and Sartorius, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Adult Immune Cell Storage Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Adult Immune Cell Storage Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Adult Immune Cell Storage Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Adult Immune Cell Storage Services market.
Adult Immune Cell Storage Services Segment by Company
Shanghai Cell Therapy Group
BGI Group
VCANBIO
CGT GLOBAL
Cordlife Group
ThermoGenesis
HealthBanks
BioLife Solutions
Sartorius
CGT GLOBAL
Cordlife Group
Aeterna Health
Cell Vault
Redermis
Innovita Research
Adult Immune Cell Storage Services Segment by Type
100ml Blood Collection Volume
150ml Blood Collection Volume
200ml Blood Collection Volume
Adult Immune Cell Storage Services Segment by Application
Personal
Commercial
Adult Immune Cell Storage Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Adult Immune Cell Storage Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Adult Immune Cell Storage Services key companies, revenue, market share, and recent developments.
3. To split the Adult Immune Cell Storage Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Adult Immune Cell Storage Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Adult Immune Cell Storage Services significant trends, drivers, influence factors in global and regions.
6. To analyze Adult Immune Cell Storage Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult Immune Cell Storage Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adult Immune Cell Storage Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult Immune Cell Storage Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Adult Immune Cell Storage Services industry.
Chapter 3: Detailed analysis of Adult Immune Cell Storage Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Adult Immune Cell Storage Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Adult Immune Cell Storage Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 100ml Blood Collection Volume
- 150ml Blood Collection Volume
- 200ml Blood Collection Volume
Applications
- Personal
- Commercial
Companies covered
- Shanghai Cell Therapy Group
- BGI Group
- VCANBIO
- CGT GLOBAL
- Cordlife Group
- ThermoGenesis
- HealthBanks
- BioLife Solutions
- Sartorius
- CGT GLOBAL
- Cordlife Group
- Aeterna Health
- Cell Vault
- Redermis
- Innovita Research
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Adult Immune Cell Storage Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Adult Immune Cell Storage Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Adult Immune Cell Storage Services Market Dynamics
- 2.1 Adult Immune Cell Storage Services Industry Trends
- 2.2 Adult Immune Cell Storage Services Industry Drivers
- 2.3 Adult Immune Cell Storage Services Industry Opportunities and Challenges
- 2.4 Adult Immune Cell Storage Services Industry Restraints
3 Adult Immune Cell Storage Services Market by Company
- 3.1 Global Adult Immune Cell Storage Services Company Revenue Ranking in 2025
- 3.2 Global Adult Immune Cell Storage Services Revenue by Company (2021-2026)
- 3.3 Global Adult Immune Cell Storage Services Company Ranking (2024-2026)
- 3.4 Global Adult Immune Cell Storage Services Company Manufacturing Base and Headquarters
- 3.5 Global Adult Immune Cell Storage Services Company Product Type and Application
- 3.6 Global Adult Immune Cell Storage Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Adult Immune Cell Storage Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Adult Immune Cell Storage Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Adult Immune Cell Storage Services Market by Type
- 4.1 Adult Immune Cell Storage Services Type Introduction
- 4.1.1 100ml Blood Collection Volume
- 4.1.2 150ml Blood Collection Volume
- 4.1.3 200ml Blood Collection Volume
- 4.2 Global Adult Immune Cell Storage Services Sales Value by Type
- 4.2.1 Global Adult Immune Cell Storage Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Adult Immune Cell Storage Services Sales Value by Type (2021-2032)
- 4.2.3 Global Adult Immune Cell Storage Services Sales Value Share by Type (2021-2032)
5 Adult Immune Cell Storage Services Market by Application
- 5.1 Adult Immune Cell Storage Services Application Introduction
- 5.1.1 Personal
- 5.1.2 Commercial
- 5.2 Global Adult Immune Cell Storage Services Sales Value by Application
- 5.2.1 Global Adult Immune Cell Storage Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Adult Immune Cell Storage Services Sales Value by Application (2021-2032)
- 5.2.3 Global Adult Immune Cell Storage Services Sales Value Share by Application (2021-2032)
6 Adult Immune Cell Storage Services Regional Value Analysis
- 6.1 Global Adult Immune Cell Storage Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Adult Immune Cell Storage Services Sales Value by Region (2021-2032)
- 6.2.1 Global Adult Immune Cell Storage Services Sales Value by Region: 2021-2026
- 6.2.2 Global Adult Immune Cell Storage Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Adult Immune Cell Storage Services Sales Value (2021-2032)
- 6.3.2 North America Adult Immune Cell Storage Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Adult Immune Cell Storage Services Sales Value (2021-2032)
- 6.4.2 Europe Adult Immune Cell Storage Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Adult Immune Cell Storage Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Adult Immune Cell Storage Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Adult Immune Cell Storage Services Sales Value (2021-2032)
- 6.6.2 South America Adult Immune Cell Storage Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Adult Immune Cell Storage Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Adult Immune Cell Storage Services Sales Value Share by Country, 2025 VS 2032
7 Adult Immune Cell Storage Services Country-level Value Analysis
- 7.1 Global Adult Immune Cell Storage Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Adult Immune Cell Storage Services Sales Value by Country (2021-2032)
- 7.2.1 Global Adult Immune Cell Storage Services Sales Value by Country (2021-2026)
- 7.2.2 Global Adult Immune Cell Storage Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Adult Immune Cell Storage Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Adult Immune Cell Storage Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Adult Immune Cell Storage Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Shanghai Cell Therapy Group
- 8.1.1 Shanghai Cell Therapy Group Company Information
- 8.1.2 Shanghai Cell Therapy Group Business Overview
- 8.1.3 Shanghai Cell Therapy Group Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Shanghai Cell Therapy Group Adult Immune Cell Storage Services Product Portfolio
- 8.1.5 Shanghai Cell Therapy Group Recent Developments
- 8.2 BGI Group
- 8.2.1 BGI Group Company Information
- 8.2.2 BGI Group Business Overview
- 8.2.3 BGI Group Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.2.4 BGI Group Adult Immune Cell Storage Services Product Portfolio
- 8.2.5 BGI Group Recent Developments
- 8.3 VCANBIO
- 8.3.1 VCANBIO Company Information
- 8.3.2 VCANBIO Business Overview
- 8.3.3 VCANBIO Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.3.4 VCANBIO Adult Immune Cell Storage Services Product Portfolio
- 8.3.5 VCANBIO Recent Developments
- 8.4 CGT GLOBAL
- 8.4.1 CGT GLOBAL Company Information
- 8.4.2 CGT GLOBAL Business Overview
- 8.4.3 CGT GLOBAL Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.4.4 CGT GLOBAL Adult Immune Cell Storage Services Product Portfolio
- 8.4.5 CGT GLOBAL Recent Developments
- 8.5 Cordlife Group
- 8.5.1 Cordlife Group Company Information
- 8.5.2 Cordlife Group Business Overview
- 8.5.3 Cordlife Group Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Cordlife Group Adult Immune Cell Storage Services Product Portfolio
- 8.5.5 Cordlife Group Recent Developments
- 8.6 ThermoGenesis
- 8.6.1 ThermoGenesis Company Information
- 8.6.2 ThermoGenesis Business Overview
- 8.6.3 ThermoGenesis Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.6.4 ThermoGenesis Adult Immune Cell Storage Services Product Portfolio
- 8.6.5 ThermoGenesis Recent Developments
- 8.7 HealthBanks
- 8.7.1 HealthBanks Company Information
- 8.7.2 HealthBanks Business Overview
- 8.7.3 HealthBanks Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.7.4 HealthBanks Adult Immune Cell Storage Services Product Portfolio
- 8.7.5 HealthBanks Recent Developments
- 8.8 BioLife Solutions
- 8.8.1 BioLife Solutions Company Information
- 8.8.2 BioLife Solutions Business Overview
- 8.8.3 BioLife Solutions Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.8.4 BioLife Solutions Adult Immune Cell Storage Services Product Portfolio
- 8.8.5 BioLife Solutions Recent Developments
- 8.9 Sartorius
- 8.9.1 Sartorius Company Information
- 8.9.2 Sartorius Business Overview
- 8.9.3 Sartorius Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Sartorius Adult Immune Cell Storage Services Product Portfolio
- 8.9.5 Sartorius Recent Developments
- 8.10 CGT GLOBAL
- 8.10.1 CGT GLOBAL Company Information
- 8.10.2 CGT GLOBAL Business Overview
- 8.10.3 CGT GLOBAL Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.10.4 CGT GLOBAL Adult Immune Cell Storage Services Product Portfolio
- 8.10.5 CGT GLOBAL Recent Developments
- 8.11 Cordlife Group
- 8.11.1 Cordlife Group Company Information
- 8.11.2 Cordlife Group Business Overview
- 8.11.3 Cordlife Group Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Cordlife Group Adult Immune Cell Storage Services Product Portfolio
- 8.11.5 Cordlife Group Recent Developments
- 8.12 Aeterna Health
- 8.12.1 Aeterna Health Company Information
- 8.12.2 Aeterna Health Business Overview
- 8.12.3 Aeterna Health Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.12.4 Aeterna Health Adult Immune Cell Storage Services Product Portfolio
- 8.12.5 Aeterna Health Recent Developments
- 8.13 Cell Vault
- 8.13.1 Cell Vault Company Information
- 8.13.2 Cell Vault Business Overview
- 8.13.3 Cell Vault Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Cell Vault Adult Immune Cell Storage Services Product Portfolio
- 8.13.5 Cell Vault Recent Developments
- 8.14 Redermis
- 8.14.1 Redermis Company Information
- 8.14.2 Redermis Business Overview
- 8.14.3 Redermis Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Redermis Adult Immune Cell Storage Services Product Portfolio
- 8.14.5 Redermis Recent Developments
- 8.15 Innovita Research
- 8.15.1 Innovita Research Company Information
- 8.15.2 Innovita Research Business Overview
- 8.15.3 Innovita Research Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Innovita Research Adult Immune Cell Storage Services Product Portfolio
- 8.15.5 Innovita Research Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst